What is Glow70?

Glow70 is a multi-pathway regenerative research blend combining three extensively studied peptides:

BPC-157 (10mg) + TB-500 (10mg) + GHK-Cu (50mg)

This formulation is designed to investigate tissue repair, collagen synthesis, recovery signaling, and skin quality pathways simultaneously.

Rather than targeting a single mechanism, Glow70 brings together:

• soft tissue healing support

• systemic recovery signaling

• skin & connective tissue remodeling

…into one concentrated 70mg laboratory-grade vial.

The result is a broad-spectrum compound stack often explored in recovery, aesthetic, and “cellular optimisation” research protocols.

What’s Inside Glow70

BPC-157 — 10mg

A gastric-derived peptide studied for tendon, ligament, muscle, and gut tissue repair.

Key research interests include:

• angiogenesis (new blood vessel formation)

• inflammation modulation

• connective tissue healing

• localized recovery support

Often associated with soft-tissue and injury-focused models.

TB-500 (Thymosin Beta-4 fragment) — 10mg

A synthetic fragment of Thymosin Beta-4 investigated for cell migration and systemic repair signaling.

Research suggests potential roles in:

• actin regulation (cell movement)

• faster tissue regeneration

• improved flexibility/mobility

• whole-body recovery effects

Commonly described as providing broader, systemic repair support compared to localized peptides.

GHK-Cu (Copper Tripeptide-1) — 50mg

A naturally occurring copper peptide widely studied in skin biology and collagen remodeling.

Associated with:

• collagen & elastin synthesis

• skin firmness and elasticity

• antioxidant activity

• wound healing pathways

• hair & follicle research

Often used in aesthetic and dermatological research settings.

Why Combine Them?

Glow70 is designed around mechanistic synergy:

• BPC-157 → initiates repair signals

• TB-500 → enhances cellular migration & systemic recovery

• GHK-Cu → improves tissue quality & collagen remodeling

Together, this allows researchers to explore:

✔ faster recovery signaling
✔ improved connective tissue integrity
✔ enhanced skin & surface appearance
✔ multi-system regeneration support

Instead of running three separate compounds, Glow70 consolidates them into one streamlined protocol.

How It Works

Glow70 may influence several overlapping biological pathways:

Angiogenesis & Blood Flow
Supports nutrient delivery to healing tissues.

Cell Migration & Repair Signaling
Encourages movement of repair cells to sites of stress or injury.

Collagen & Extracellular Matrix Support
Promotes structural rebuilding of skin and connective tissue.

Inflammation Modulation
May assist with resolving post-injury inflammatory responses.

Skin & Aesthetic Remodeling
Supports elasticity, tone, and surface regeneration pathways.

Note: Evidence is primarily preclinical and experimental. Human clinical data remain limited.

Forms & Delivery Methods

Because Glow70 is a multi-peptide blend, it is typically reconstituted for laboratory research use.

Common experimental approaches include:

Subcutaneous research protocols
Often used for systemic or localized recovery signaling.

Topical / cosmetic research (GHK-Cu focus)
Some researchers explore diluted topical formats for skin-focused applications.

Delivery method may influence whether outcomes are more localized (skin) or systemic (soft tissue repair).

Typical Dosing Guidance

Sources: Swolverine peptide education resources and general peptide research summaries

As an investigational blend, no approved dosing standards exist.

Experimental practices commonly reference:

~200–500 mcg total peptide content daily
Split dosing sometimes used
Cycle length: 4–8 weeks often discussed

Protocols are typically adjusted depending on whether the focus is:

• recovery

• connective tissue

• or aesthetic/skin outcomes

Important: Dosing reflects experimental research practices — not medical prescriptions.

Typical Uses & Applications

Recovery & Soft Tissue Support

Tendon, ligament, and muscle repair research

Skin & Aesthetic Research

Collagen density, elasticity, and tissue quality pathways

Post-Stress or High-Load Protocols

Recovery-focused models in training or physical stress contexts

Regenerative / Longevity Stacks

Often explored alongside NAD+, MOTS-c, or metabolic optimisation compounds

Safety & Side Effects

Individual components are generally described as well-tolerated in preclinical settings.

Anecdotal reports may include:

• mild injection site irritation

• temporary flushing (GHK-Cu related)

• lightheadedness or nausea in some cases

Comprehensive human safety trials are limited.

Regulatory & Evidence Context

Glow70 and its constituent peptides are not approved by major health authorities for therapeutic use.

Use remains investigational and limited to laboratory and educational settings.

Some peptides in this category are restricted in competitive sport environments (e.g., WADA).

Regenix Quality Commitment

• Purity verified via HPLC

• Traceable sourcing

• Small batch oversight

• Laboratory-grade peptide research compounds only

Important Notice

Supplied strictly for laboratory research and educational purposes.
Not for human consumption or medical use.